Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

EBMT 2020

Watch all EBMT 2020 Videos

View all
10:00
Graft failure after unmanipulated haplo-HSCT with PT-Cy in AML
Annalisa Ruggeri • 26 Aug 2020
1:31
Autoimmune cytopenias following allo-HSCT
Carlo Dufour • 25 Aug 2020
6:51
Role of the EBMT registry on reporting CAR T-cell outcomes
Christian Chabannon • 31 Aug 2020

Multiple Myeloma

View all
2:55
COVID-19 & multiple myeloma: patient management
Florent Malard • 20 Aug 2020
4:15
CAR-T cells: current climate and future perspectives in multiple myeloma
Nico Gagelmann • 27 Aug 2020
2:29
HDAC inhibitors: panobinostat for R/R myeloma
Noopur Raje • 25 Aug 2020
5:06
Treatment strategies for smoldering myeloma
Noopur Raje • 26 Aug 2020

Lymphoma

View all
5:01
PORTIA: tisagenlecleucel and pembrolizumab in R/R DLBCL
Edmund Waller • 23 Aug 2020
2:41
Gray zone lymphoma: pembrolizumab
Fernando Barroso Duarte • 20 Aug 2020

Leukemia

View all
4:36
AML haplo-HSCT outcomes
Ali Bazarbachi • 23 Aug 2020
3:06
CLL: the GREEN study
Véronique Leblond • 20 Aug 2020

Graft-versus-host disease

View all
6:15
Standardizing chronic GvHD grading and assessment
John Murray • 24 Aug 2020
2:56
Preventive and therapeutic interventions for the microbiota
Florent Malard • 24 Aug 2020
1:37
Transplantation: a holistic approach
Jaap Jan Boelens • 23 Aug 2020
3:35
Role of the microbiome in GvHD
Sara Deola • 30 Aug 2020

COVID-19

View all
3:08
Treatment strategies for cHL patients after auto-HSCT
Anna Sureda • 24 Aug 2020
4:28
Transplantation, COVID-19 & Brazil
Fernando Barroso Duarte • 20 Aug 2020
2:55
COVID-19 & multiple myeloma: patient management
Florent Malard • 20 Aug 2020
6:50
Spain & COVID-19: HSCT, CAR-T and clinical practice
Anna Sureda • 19 Aug 2020
The content of VJHemOnc is intended for healthcare professionals